{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:35Z","timestamp":1792788035311,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218926","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:54:18Z","timestamp":1792652058000},"page":"218926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fenofibrate enhances systemic antitumor efficacy of high- and low-dose radiotherapy plus PD-1 blockade through CD8+ T-cell metabolic reprogramming and LDRT tumor conditioning"],"prefix":"10.1016","author":[{"given":"Meidan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-8001","authenticated-orcid":false,"given":"Liqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Shirafkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Gaedicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Ligia","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Firat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Multhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-0975","authenticated-orcid":false,"given":"Gabriele","family":"Niedermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218926_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.canlet.2026.218926_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.canlet.2026.218926_bib3","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canlet.2026.218926_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/1078-0432.CCR-25-1603","article-title":"Facts and Hopes in Radioimmunotherapy for Localized Stages of Cancer","volume":"32","author":"Bosi","year":"2026","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.canlet.2026.218926_bib5","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1158\/1078-0432.CCR-24-2522","article-title":"Facts and Hopes in Radioimmunotherapy of Oligometastatic Disease","volume":"31","author":"Huang","year":"2025","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.canlet.2026.218926_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canlet.2026.218926_bib7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00262-020-02587-8","article-title":"Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature","volume":"69","author":"Watanabe","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.canlet.2026.218926_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41568-025-00903-x","article-title":"Radiation as an immune modulator: mechanisms and implications for combination with immunotherapy","volume":"26","author":"Darragh","year":"2026","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.canlet.2026.218926_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","article-title":"CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.canlet.2026.218926_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.canlet.2026.218926_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218926_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41577-023-00867-9","article-title":"Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1","volume":"23","author":"Chamoto","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.canlet.2026.218926_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.1242454","article-title":"Fueling Immunity: Insights into Metabolism and Lymphocyte Function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218926_bib14","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.canlet.2026.218926_bib15","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2026.218926_bib16","article-title":"Clinical efficacy of combining fenofibrate with statins in patients with diabetes and hyperlipidemia: a meta-analysis","volume":"17","author":"Huang","year":"2026","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.canlet.2026.218926_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120555","article-title":"Not all fibrates are made equal: Learning from biology and clinical trials","volume":"411","author":"Zambon","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.canlet.2026.218926_bib18","doi-asserted-by":"crossref","unstructured":"Rakhshandehroo M, Knoch B, M\u00fcller M, Kersten S. Peroxisome Proliferator-Activated Receptor Alpha Target Genes. PPAR Research. 2010;2010:1\u201320. https:\/\/doi.org\/10.1155\/2010\/612089","DOI":"10.1155\/2010\/612089"},{"key":"10.1016\/j.canlet.2026.218926_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218926_bib20","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-21-0052","article-title":"PPAR\u03b1 Agonist Fenofibrate Enhances Cancer Vaccine Efficacy","volume":"81","author":"Chekaoui","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/j.canlet.2026.218926_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.omto.2023.100744","article-title":"Treatment with the PPAR\u03b1 agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma","volume":"31","author":"Hasanpourghadi","year":"2023","journal-title":"Molecular Therapy - Oncolytics"},{"key":"10.1016\/j.canlet.2026.218926_bib22","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/1078-0432.CCR-23-3433","article-title":"PPAR\u03b1 Agonism Enhances Immune Response to Radiotherapy While Dietary Oleic Acid Results in Counteraction","volume":"30","author":"Ross","year":"2024","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.canlet.2026.218926_bib23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41467-023-37825-x","article-title":"Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice","volume":"14","author":"Onyshchenko","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.canlet.2026.218926_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1158\/1078-0432.CCR-22-1591","article-title":"Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect","volume":"29","author":"Luo","year":"2023","journal-title":"Clinical Cancer Research"},{"issue":"12","key":"10.1016\/j.canlet.2026.218926_bib25","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.4049\/jimmunol.157.12.5536","article-title":"Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines","volume":"157","author":"Rodolfo","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.canlet.2026.218926_bib26","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1158\/0008-5472.CAN-15-3451","article-title":"Checkpoint Antibodies but not T Cell\u2013Recruiting Diabodies Effectively Synergize with TIL-Inducing \u03b3-Irradiation","volume":"76","author":"Hettich","year":"2016","journal-title":"Cancer Research"},{"key":"10.1016\/j.canlet.2026.218926_bib27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","article-title":"SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution","volume":"32","author":"Arg\u00fcello","year":"2020","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.canlet.2026.218926_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cyto.a.23705","article-title":"Objective Method Using MitoTracker\u00ae Fluorescent Dyes to Assess Mitochondrial Mass in T Cells by Flow Cytometry","volume":"95","author":"Clutton","year":"2019","journal-title":"Cytometry Pt A"},{"key":"10.1016\/j.canlet.2026.218926_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013055","article-title":"CD4+ T cells facilitate the RT-induced abscopal effect by promoting antigen cross-presentation to CD8+ T cells at unirradiated tumor sites","volume":"14","author":"Rao","year":"2026","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2026.218926_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218926_bib31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","article-title":"Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection","volume":"51","author":"Hudson","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218926_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2013.10.007","article-title":"Interferon Regulatory Factor 4 Sustains CD8+ T Cell Expansion and Effector Differentiation","volume":"39","author":"Yao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218926_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2009.06.021","article-title":"Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses","volume":"31","author":"Kallies","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218926_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","article-title":"Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction","volume":"567","author":"Liu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218926_bib35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","article-title":"NR4A transcription factors limit CAR T cell function in solid tumours","volume":"567","author":"Chen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218926_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145407","article-title":"Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease","volume":"776","author":"Henriques","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2026.218926_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","article-title":"Lipin 1 is an inducible amplifier of the hepatic PGC-1\u03b1\/PPAR\u03b1 regulatory pathway","volume":"4","author":"Finck","year":"2006","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.canlet.2026.218926_bib38","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","article-title":"A general introduction to the biochemistry of mitochondrial fatty acid \u03b2\u2010oxidation","volume":"33","author":"Houten","year":"2010","journal-title":"J of Inher Metab Disea"},{"key":"10.1016\/j.canlet.2026.218926_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41421-024-00722-8","article-title":"Structural insights into human ABCD3-mediated peroxisomal acyl-CoA translocation","volume":"10","author":"Li","year":"2024","journal-title":"Cell Discov"},{"key":"10.1016\/j.canlet.2026.218926_bib40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.mam.2012.07.010","article-title":"SLC27 fatty acid transport proteins","volume":"34","author":"Anderson","year":"2013","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.canlet.2026.218926_bib41","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1101\/gad.269894.115","article-title":"Mitochondrial biogenesis and dynamics in the developing and diseased heart","volume":"29","author":"Dorn","year":"2015","journal-title":"Genes Dev"},{"key":"10.1016\/j.canlet.2026.218926_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1073\/pnas.0711281105","article-title":"PPAR\u03b1 agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition","volume":"105","author":"Panigrahy","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.canlet.2026.218926_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/0008-5472.CAN-13-1928","article-title":"PPAR\u03b1 Activation Can Help Prevent and Treat Non\u2013Small Cell Lung Cancer","volume":"74","author":"Skrypnyk","year":"2014","journal-title":"Cancer Research"},{"key":"10.1016\/j.canlet.2026.218926_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005940","article-title":"Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models","volume":"11","author":"Kansal","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2026.218926_bib45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/ijc.34801","article-title":"Low\u2010dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives","volume":"154","author":"Zhou","year":"2024","journal-title":"Intl Journal of Cancer"},{"key":"10.1016\/j.canlet.2026.218926_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13046-025-03281-2","article-title":"Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects","volume":"44","author":"Rafiq","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.canlet.2026.218926_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000627","article-title":"Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma","volume":"8","author":"Boutros","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2026.218926_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006235","article-title":"Adding liposomal doxorubicin enhances the abscopal effect induced by radiation\/\u03b1PD1 therapy depending on tumor cell mitochondrial DNA and cGAS\/STING","volume":"11","author":"Wang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2026.218926_bib49","doi-asserted-by":"crossref","unstructured":"Yin L. Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer. 2020;108. 2020 Sep 1;108(1):212-224. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.05.002.","DOI":"10.1016\/j.ijrobp.2020.05.002"},{"key":"10.1016\/j.canlet.2026.218926_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"20","key":"10.1016\/j.canlet.2026.218926_bib51","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1158\/1078-0432.CCR-23-0315","article-title":"Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy \u00fe Sintilimab for Treatment-Na\u00efve Stage IV PD-L1\u00fe Non\u2013Small Cell Lung Cancer Patients","volume":"29","author":"Zhou","year":"2023","journal-title":"CLINICAL CANCER RESEARCH"},{"key":"10.1016\/j.canlet.2026.218926_bib52","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/ncomms8458","article-title":"Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints","volume":"6","author":"Mikucki","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.canlet.2026.218926_bib53","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-19-1344","article-title":"Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3\/CXCL10-Mediated T-cell Recruitment","volume":"25","author":"Luo","year":"2019","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.canlet.2026.218926_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103366","article-title":"Metabolism of cancer cells commonly responds to irradiation by a transient early mitochondrial shutdown","volume":"24","author":"Krysztofiak","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2026.218926_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1620433114","article-title":"Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity","volume":"114","author":"Chamoto","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.canlet.2026.218926_bib56","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-18-0095","article-title":"PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8+ T Cells and Facilitates Anti\u2013PD-1 Therapy","volume":"6","author":"Chowdhury","year":"2018","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.canlet.2026.218926_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0021","article-title":"Combination bezafibrate and nivolumab treatment of patients with advanced non\u2013small cell lung cancer","volume":"14","author":"Tanaka","year":"2022","journal-title":"Sci Transl Med"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:16:34Z","timestamp":1792786594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"alternative-id":["S0304383526006907"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218926","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate enhances systemic antitumor efficacy of high- and low-dose radiotherapy plus PD-1 blockade through CD8+ T-cell metabolic reprogramming and LDRT tumor conditioning","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218926"}}